Results 131 to 140 of about 1,585 (172)
Some of the next articles are maybe not open access.

Vanillylamide-Based Propanolamine Derivative Displays α/β-Adrenoceptor Blocking and Vasodilating Properties

Journal of Cardiovascular Pharmacology, 2002
A propanolamine derivative with vanillylamide base, KMUP 880602, was first investigated under in vivo and in vitro conditions. IV KMUP 880602 (0.1, 0.5, 1.0, and 2.0 mg/kg) produced dose-dependent hypotensive and bradycardia responses in pentobarbital-anesthetized Wistar rats. KMUP 880602 also markedly inhibited both the tachycardia effects induced by (
Jwu-Lai, Yeh   +7 more
openaire   +2 more sources

Synthesis and beta-adrenergic antagonist activity of novel (3-cyanodihydropyridyl)propanolamines.

Drug design and discovery, 1992
The synthesis and beta-adrenergic antagonist activities of 1-(1-dihydropyridyl)-3-alkylamino-2-propanols (9-16) in which the aryloxy group of aryloxypropanolamines (1) is replaced by a 1-[2-t-(n-)butyl-3-cyano-1,2-dihydropyridyl] (9-12) or 1-[6-t-(n-)butyl-3-cyano-1,6-dihydropyridyl] (13-16) moiety is described.
D, Vo, M W, Wolowyk, E E, Knaus
openaire   +2 more sources

[p-(Thienylcarboxamido)phenoxy]propanolamine derivatives as diuretic and .beta.-adrenergic receptor blocking agents

Journal of Medicinal Chemistry, 1986
The synthesis of [[(thienylcarbonyl)amino]phenoxy]propanolamines and their beta-adrenergic blocking and diuretic activity are described. Structure-activity relationships demonstrated that ortho substitution of the phenoxy ring with an hydrogen or an ester function leads to compounds possessing both activities.
E, Bouley   +4 more
openaire   +2 more sources

[(Arylcarbonyl)oxy]propanolamines. 1. Novel .beta.-blockers with ultrashort duration of action

Journal of Medicinal Chemistry, 1984
Novel [(arylcarbonyl)oxy]propanolamines were synthesized and investigated as potential ultrashort-acting beta-adrenergic receptor blockers. Many of these analogues exhibited good potency and short duration. The N-ureidoalkyl analogue 85 (ACC-9089) has a potency equal to propranolol and a duration of action of about 21 min in the dog.
S T, Kam   +9 more
exaly   +3 more sources

Synthesis and Properties of Cu(Benzoylacetone-ethanolamine) and Cu(Benzoylacetone-propanolamine)

Synthesis and Reactivity in Inorganic and Metal-Organic Chemistry, 1991
Abstract The Schiff base resulting from benzoylacetone and ethanolamine or propanolamine has been used to form copper(II) complexes. Cu(benzoylacetone-ethanolamine) is tetrameric with a ferromagnetic ground state. Cu(benzoylacetone-propanolamine) is dimeric with overall antiferromagnetic interaction and a singlet ground state.
K. Hines, L. J. Theriot
openaire   +1 more source

Persistence and Biodegradation of Monoethanolamine and 2-Propanolamine at an Abandoned Industrial Site

Environmental Science & Technology, 2005
Soil and groundwater samples were collected at the site of a former chemical processing plant in areas impacted by accidental releases of MEA (monoethanolamine) and IPA (2-propanolamine or isopropanolamine). Although their use had ceased ca. 10 years before sample collection, soils collected at contamination sites had MEA concentrations ranging from ca.
Steven B, Hawthorne   +4 more
openaire   +2 more sources

Synthesis of propanolamine side chain deuterated propranolol, propranolol‐diol and 4‐hydroxypropranol

Journal of Labelled Compounds and Radiopharmaceuticals, 1978
AbstractSyntheses of 1‐(isopropylamino)‐3‐(1‐naphthyloxy)‐2‐propanol‐1,1,2,3,3‐d5 (1), 3‐(1‐naphthyloxy)‐1,2‐propanediol‐1,1,2,3,3‐d5 (2) and 1‐(isopropylamino)‐3‐(4‐hydroxy‐1‐naphthyloxy)‐2‐propanol‐1,1,2,3,3‐d5 (3) from epichlorohydrin‐d5 are described. Treatment of epichlorohydrin‐d5 with 1‐naphthol, in the presence of a catalytic amount of pyridine,
Richard B. Walker, Wendel L. Nelson
openaire   +1 more source

Flavones. 1. Synthesis and antihypertensive activity of (3-phenylflavonoxy)propanolamines without .beta.-adrenoceptor antagonism

Journal of Medicinal Chemistry, 1987
The synthesis of a series of (3-phenylflavonoxy)propanolamines is described. These compounds were evaluated for potential antihypertensive activity in spontaneously hypertensive rats, as well as for in vivo and in vitro evidence of beta-adrenoceptor antagonism. Some of the compounds of this series exhibited effective antihypertensive properties but did
E S, Wu   +7 more
exaly   +3 more sources

New chiral and isomeric cyclopropyl ketoxime propanolamine derivatives with potent .beta.-adrenergic blocking properties

Journal of Medicinal Chemistry, 1985
The synthesis of R-(+) and S-(-) isomers of O-[3-tert-butylamino)-2-hydroxypropyl] cyclopropyl methyl ketone oxime (falintolol) is described. The syn and anti isomers of falintolol were obtained in two different ways from cyclopropyl methyl ketoxime or from falintolol.
M, Bouzoubaa   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy